C.G.G. Link
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Epilepsy research and treatment
-
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 7
- Electroconvulsive Therapy Studies 3
- Bipolar Disorder and Treatment 3
-
- Pituitary Gland Disorders and Treatments 3
- Growth Hormone and Insulin-like Growth Factors 1
- Co-authors
- Joseph Peuskens (1 shared paper)Barbara B. Kowalcyk (2 shared papers)David Copolov (1 shared paper)David J. King (2 shared papers)Lisa A. Arvanitis (4 shared papers)Barry D. Zussman (1 shared paper)Barbara G. Miller (4 shared papers)Jeffrey M. Goldstein (1 shared paper)
- Journals
- European Neuropsychopharmacology (3 papers)Acta Psychiatrica Scandinavica (3 papers)Biological Psychiatry (2 papers)Psychopharmacology (1 paper)European Psychiatry (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
C.G.G. Link
14 papers receiving 537 citations
Peers
Comparison fields: 5 of 64
- Psychiatry and Mental health 480
- Biological Psychiatry 29
- Pharmacology 110
- Philosophy 62
- Cellular and Molecular Neuroscience 65
Countries citing papers authored by C.G.G. Link
This map shows the geographic impact of C.G.G. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.G.G. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.G.G. Link more than expected).
Fields of papers citing papers by C.G.G. Link
This network shows the impact of papers produced by C.G.G. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.G.G. Link. The network helps show where C.G.G. Link may publish in the future.
Co-authors
The 16 scholars most cited alongside C.G.G. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 210 | |
| 2 | 2000 | 119 | |
| 3 | 1989 | 71 | |
| 4 | 1998 | 62 | |
| 5 | Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). | 1996 | 48 |
| 6 | 1996 | 42 | |
| 7 | 1990 | 19 | |
| 8 | 1994 | 8 | |
| 9 | 1992 | 4 | |
| 10 | 1996 | 4 | |
| 11 | 1996 | 4 | |
| 12 | 1996 | 3 | |
| 13 | 1995 | 2 | |
| 14 | 1995 | 2 |
About C.G.G. Link
C.G.G. Link is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism, Pharmacology, Physiology and Experimental and Cognitive Psychology, having authored 14 papers that have together received 598 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (7 papers), Pituitary Gland Disorders and Treatments (3 papers), Electroconvulsive Therapy Studies (3 papers), Bipolar Disorder and Treatment (3 papers), Treatment of Major Depression (3 papers), Diet and metabolism studies (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Growth Hormone and Insulin-like Growth Factors (1 paper). The work is most often cited by research in Psychiatry and Mental health (480 citations), Biological Psychiatry (29 citations), Pharmacology (110 citations), Philosophy (62 citations) and Cellular and Molecular Neuroscience (65 citations). C.G.G. Link has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Joseph Peuskens, Barbara B. Kowalcyk, David Copolov, David J. King, Lisa A. Arvanitis, Barry D. Zussman, Barbara G. Miller, Jeffrey M. Goldstein, Steven Richard Hirsch and Mark B. Hamner. Their work appears in journals such as European Neuropsychopharmacology, Acta Psychiatrica Scandinavica, Biological Psychiatry, Psychopharmacology and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.